46 results on '"Isophane Insulin, Human"'
Search Results
2. The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
3. Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes (PREDICTIVE™)
4. Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes (3L)
5. A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin (iDEAt2)
6. Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
7. Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
8. NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
9. Safety of Insulin Detemir in Children With Type 1 Diabetes
10. Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
11. Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes
12. Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
13. Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
14. Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
15. Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
16. Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
17. Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
18. Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
19. Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
20. Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard® (EVIDENCE)
21. Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
22. Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone
23. Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
24. Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
25. Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes
26. Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
27. Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes
28. Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
29. Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes
30. Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia
31. Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes
32. Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
33. Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
34. Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes
35. Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
36. Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
37. Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes
38. Human Insulin NPH and Insulin Aspart in Type 1 Diabetes
39. Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
40. Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
41. Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During 'Real-life' Usage in Germany
42. Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
43. Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment
44. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
45. Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
46. Bioequivalence of Two Insulatard® Formulations in Healthy Subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.